# New Zealand Mobility Aid Market Size, Share & Forecast, By Product Type, End User & Distribution Channel, 2026–2031 --- ## Market Overview # CHAPTER 1 - Market Overview The New Zealand Mobility Aid Market serves users through publicly funded equipment programmes, injury rehabilitation schemes, institutional procurement and private retail. An estimated 17% of people living in New Zealand households were disabled in 2023, equivalent to 851,000 people. This creates recurring demand for walking supports, wheelchairs, mobility scooters, transfer equipment, replacement components and professional fitting services. Auckland is the largest commercial demand centre because it combines the country's largest population base, tertiary hospitals, rehabilitation providers, aged-care facilities and specialist mobility retailers. National distribution remains important because equipment users are geographically dispersed. Suppliers therefore combine Auckland inventory with service coverage through regional branches, approved repair networks and contracted assessors operating across the North and South Islands. Medical devices supplied commercially in New Zealand must generally be notified through the Web Assisted Notification of Devices database. Sponsors must complete notification within 30 calendar days of becoming responsible for a device. The framework raises the importance of sponsor capability, product traceability and post-market support, while remaining a notification system rather than a formal pre-market approval process. The market is structurally import dependent, particularly for powered wheelchairs, electronic controls, batteries, motors and premium mobility scooters. Wheelchair imports rose from NZD 9.9 million in 2010 to NZD 15.4 million in 2019, before distributor margins and service revenue. This dependence makes foreign exchange, freight availability and international manufacturer relationships material considerations for inventory planning and pricing. ## KPIs at a Glance * Market Value: USD 122 million (2025) * Dominant Region: Auckland * Dominant Segment: Powered Wheelchairs & Mobility Scooters (fastest growing) * Total Number of Players: 42 ## Future Outlook The New Zealand Mobility Aid Market is projected to increase from USD 122 million in 2025 to USD 185 million by 2031. The resulting 7.19% forecast CAGR exceeds the 6.51% historical CAGR recorded during 2020–2025. Growth will be supported by a population aged 65 years and older approaching one million, longer periods of community-based living and expanding demand for configured powered mobility. Volume is projected to rise from approximately 110,000 mobility-aid units in 2025 to 150,000 units in 2031, while product mix shifts toward higher-value electronic, modular and customised equipment. Government-funded demand will remain an anchor, but private-pay retail, aged-care procurement and replacement purchases will become more commercially important. Disability Support Services currently funds environmental support services for about 100,000 people annually, including approximately 50,000 recipients of equipment and modification services. Suppliers with national repair coverage, clinical configuration capabilities and access to approved product ranges will be positioned to capture premium profit pools. Inventory financing and foreign exchange exposure will remain constraints because most powered products and components are imported. --- | | | | --- | --- | | **7.19%** Forecast CAGR | **$185 Mn** 2031 Projection | --- | | | | | | --- | --- | --- | --- | | Base Year **2025** | Historical Period **2020–2025** | Forecast Period **2026–2031** | Historical CAGR **6.51%** | --- ## Scope of the Report # CHAPTER 2 - Scope of the Market * **Geographic Coverage:** New Zealand * **Historical Period:** 2020–2025 * **Base Year:** 2025 * **Forecast Period:** 2026–2031 * **Market Segments Covered:** 7 primary segmentation dimensions (Product Type, Care Setting, End User, Application, Distribution Channel, Technology, Geography) * **Companies Covered:** Top 10 key players profiled * **Currency & Units:** USD, values expressed in USD Mn ### Segmentation Data Tree * Product Type + Manual Wheelchairs - Standard Folding Wheelchairs - Lightweight Active Wheelchairs + Powered Wheelchairs & Mobility Scooters - Powered Wheelchairs - Three-Wheel and Four-Wheel Scooters + Walking Aids - Walkers and Rollators - Canes, Crutches and Walking Frames + Transfer & Positioning Mobility Equipment - Patient Transfer Aids - Standing and Positioning Systems * Care Setting + Home and Community Care - Private Residences - Supported Independent Living + Hospitals and Rehabilitation Centres - Acute Hospitals - Rehabilitation Clinics + Aged Residential Care - Rest Homes - Hospital-Level Aged Care + Disability Support and Educational Settings - Community Disability Providers - Specialist Education Facilities * End User + Older Adults - Independent Older Users - Care-Supported Older Users + Adults with Physical Disabilities - Permanent Mobility Impairment - Progressive Neuromuscular Conditions + Injury Rehabilitation Patients - Short-Term Recovery Users - Serious Injury Claimants + Paediatric Users - Early Intervention Users - School-Age Complex Mobility Users * Application + Daily Ambulation - Indoor Movement - Local Outdoor Movement + Long-Distance Community Mobility - Urban Community Travel - Recreational Mobility + Post-Acute Rehabilitation - Orthopaedic Recovery - Neurological Rehabilitation + Complex Seating and Postural Support - Pressure Management - Custom Postural Positioning * Distribution Channel + Government-Funded Equipment Services - Disability Support Services Funding - ACC-Funded Rehabilitation Equipment + Specialist Mobility Retailers - Independent Mobility Stores - National Specialist Chains + Healthcare Institutions and Procurement Panels - Hospital Procurement - Aged-Care Group Procurement + Direct-to-Consumer E-Commerce - Supplier-Owned Online Stores - General Healthcare Marketplaces * Technology + Manual and Mechanical - Fixed Mechanical Systems - Foldable Mechanical Systems + Electrically Powered - Standard Electronic Controls - Expandable Electronic Controls + Smart Connected and Sensor-Enabled - Remote Diagnostics - Collision and Stability Assistance + Custom Modular and 3D-Fitted - Modular Seating Systems - Digitally Fitted Components * Geography + Auckland - Central and North Auckland - South and West Auckland + Wellington - Wellington City - Hutt Valley and Porirua + Canterbury - Christchurch - Wider Canterbury + Rest of New Zealand - Other North Island Regions - Other South Island Regions --- ## Market Trajectory # CHAPTER 3 - Market Size, Growth Forecast and Trends This section evaluates the historical market size, analyzes year-over-year growth dynamics, and presents forecast projections supported by market performance indicators and demand-side drivers. ### Historical and Projected Market Size | Year | Market Size (USD Mn) | Period | | --- | --- | --- | | 2020 | 89 | Historical | | 2021 | 94 | Historical | | 2022 | 100 | Historical | | 2023 | 107 | Historical | | 2024 | 114 | Historical | | 2025 | 122 | Base Year | | 2026F | 131 | Forecast | | 2027F | 140 | Forecast | | 2028F | 150 | Forecast | | 2029F | 161 | Forecast | | 2030F | 173 | Forecast | | 2031F | 185 | Forecast | ### YoY Growth Rate | Year | YoY Growth (%) | Primary Growth Factor | | --- | --- | --- | | 2021 | 5.62% | Community-care equipment demand | | 2022 | 6.38% | Supply normalization and replacement purchases | | 2023 | 7.00% | Higher powered-mobility mix | | 2024 | 6.54% | Funding-related demand and price increases | | 2025 | 7.02% | Ageing population and complex rehabilitation demand | | 2026F | 7.38% | Approved-range refresh and private-pay expansion | | 2027F | 6.87% | Regional service-network expansion | | 2028F | 7.14% | One million residents aged 65 years or older | | 2029F | 7.33% | Smart powered-mobility adoption | | 2030F | 7.45% | Replacement cycle and premium product mix | | 2031F | 6.94% | Market maturation with sustained volume growth | ### Market Value vs Volume Growth | Year | Market Value Growth (%) | Unit Volume Growth (%) | Blended ASP Growth (%) | | --- | --- | --- | --- | | 2020 | - | - | - | | 2021 | 5.62% | 4.65% | 0.92% | | 2022 | 6.38% | 5.56% | 0.78% | | 2023 | 7.00% | 5.26% | 1.65% | | 2024 | 6.54% | 5.00% | 1.47% | | 2025 | 7.02% | 4.76% | 2.15% | | 2026F | 7.38% | 5.45% | 1.82% | | 2027F | 6.87% | 5.17% | 1.61% | | 2028F | 7.14% | 4.92% | 2.12% | | 2029F | 7.33% | 5.47% | 1.77% | | 2030F | 7.45% | 5.19% | 2.16% | ### Historical Market Performance (2020–2025) Historical growth accelerated after 2021 as replacement demand recovered and suppliers restored access to imported equipment. The strongest annual increase occurred in 2023 at 7.00%, reflecting higher availability of powered mobility products and increased configuration revenue. Annual unit supply rose from approximately 86,000 units in 2020 to 110,000 in 2025. The blended selling price increased from USD 1,035 to USD 1,109 per unit as powered wheelchairs, specialised seating, batteries and customised components formed a larger proportion of expenditure. ### Forecast Market Outlook (2026–2031) The forecast period is expected to deliver 7.19% CAGR, with annual value growth remaining close to 7% throughout the period. Unit volume is projected to reach 150,000 by 2031, representing approximately 5.3% annual growth from 2025. Value growth will run ahead of volume because electrically powered and custom-configured products command materially higher prices than standard walking aids. Public funding will underpin clinical demand, while retail mobility scooters, lightweight travel wheelchairs and digitally fitted seating will expand the private-pay revenue pool. --- ## Market Breakdown # CHAPTER 4 - Market Breakdown The market's transition toward powered and configurable mobility creates a value growth profile that exceeds underlying unit demand. The detailed KPI spine below highlights the interaction between annual equipment volume, public funding exposure and blended selling prices. | Year | Market Size (USD Mn) | YoY Growth (%) | Annual Units Supplied (000) | Government-Funded Demand Share (%) | Blended ASP (USD/Unit) | Period | | --- | --- | --- | --- | --- | --- | --- | | 2020 | 89 | - | 86 | 58% | 1,035 | Historical | | 2021 | 94 | 5.62% | 90 | 59% | 1,044 | Historical | | 2022 | 100 | 6.38% | 95 | 59% | 1,053 | Historical | | 2023 | 107 | 7.00% | 100 | 60% | 1,070 | Historical | | 2024 | 114 | 6.54% | 105 | 60% | 1,086 | Historical | | 2025 | 122 | 7.02% | 110 | 61% | 1,109 | Base Year | | 2026 | 131 | 7.38% | 116 | 61% | 1,129 | Forecast and Latest Operating KPIs | | 2027 | 140 | 6.87% | 122 | 60% | 1,148 | Forecast and Industry Outlook | | 2028 | 150 | 7.14% | 128 | 60% | 1,172 | Forecast and Industry Outlook | | 2029 | 161 | 7.33% | 135 | 59% | 1,193 | Forecast and Industry Outlook | | 2030 | 173 | 7.45% | 142 | 59% | 1,218 | Forecast and Industry Outlook | | 2031 | 185 | 6.94% | 150 | 58% | 1,233 | Forecast and Industry Outlook | **KPI 1, Annual Units Supplied:** **110,000 units, 2025, New Zealand**. Volume reflects privately purchased equipment and products supplied through clinical funding pathways. Approximately 50,000 people receive publicly funded equipment and modification services annually, providing a recurring demand floor for approved products, repairs and replacements. **KPI 2, Government-Funded Demand Share:** **61%, 2025, New Zealand**. Public procurement gives approved suppliers predictable order flows but creates tender, documentation and service obligations. Budget 2025 allocated average annual new operating expenditure of NZD 255 million to Disability Support Services, supporting system capacity while maintaining strong cost-control pressure. **KPI 3, Blended ASP:** **USD 1,109 per unit, 2025, New Zealand**. The blended figure masks substantial category dispersion. Approved power-wheelchair configurations range from approximately NZD 5,000–6,000 for lower configurations to more than NZD 20,000 for complex powered systems, creating attractive configuration and after-sales revenue pools. --- --- ## Market Segmentation # CHAPTER 5 - Market Segmentation Framework Comprehensive analysis across key dimensions providing insights into market structure, consumer preferences, and distribution patterns. | | | | | --- | --- | --- | | **No of Segments:** 7 | **Dominant Segment:** Product Type | **Fastest Growing Segment:** Technology | ### Segmentation Framework | Priority | Level-1 Segment / Taxonomy Dimension | Level-2 Sub-Segments | | --- | --- | --- | | 1 | Product Type | Manual Wheelchairs; Powered Wheelchairs & Mobility Scooters; Walking Aids; Transfer & Positioning Mobility Equipment | | 2 | Care Setting | Home and Community Care; Hospitals and Rehabilitation Centres; Aged Residential Care; Disability Support and Educational Settings | | 3 | End User | Older Adults; Adults with Physical Disabilities; Injury Rehabilitation Patients; Paediatric Users | | 4 | Application | Daily Ambulation; Long-Distance Community Mobility; Post-Acute Rehabilitation; Complex Seating and Postural Support | | 5 | Distribution Channel | Government-Funded Equipment Services; Specialist Mobility Retailers; Healthcare Institutions and Procurement Panels; Direct-to-Consumer E-Commerce | | 6 | Technology | Manual and Mechanical; Electrically Powered; Smart Connected and Sensor-Enabled; Custom Modular and 3D-Fitted | | 7 | Geography | Auckland; Wellington; Canterbury; Rest of New Zealand | ### Key Segmentation Takeaways Comprehensive analysis across all extracted segmentation dimensions providing insights into market structure, consumer preferences, and distribution patterns. **Product Type** - Product category is the primary revenue-allocation dimension because unit prices vary substantially between basic walking aids and complex powered wheelchairs. Powered Wheelchairs & Mobility Scooters generate the largest value pool through higher selling prices, battery replacement, electronics, configuration and servicing, while Walking Aids remain the largest category by unit volume. **Technology** - Technology is the fastest-growing dimension as electronic controls, powered seating, remote diagnostics and modular customisation expand the addressable user base. Smart Connected and Sensor-Enabled products will grow from a small base, while Custom Modular and 3D-Fitted systems gain adoption among complex rehabilitation users requiring better pressure management, postural support and long-term adjustability. --- ## Regional Analysis # CHAPTER 6 - Regional Analysis New Zealand ranks behind Australia and Singapore but ahead of selected comparable small developed markets in the assessed peer set. Its position reflects a large disability-related demand base, national public funding pathways and high import dependence, while market scale remains constrained by population size. ### KPI Summary * Focus Country Ranking: **3rd** * Focus Country Market Size: **USD 122 Mn** * New Zealand CAGR (2026–2031): **7.19%** | Country | Market Size (USD Mn, 2025) | CAGR (%) | Population Aged 65+ (%) | Estimated Mobility-Aid Import Dependence (%) | | --- | --- | --- | --- | --- | | New Zealand | 122 | 7.19% | 17.0% | 82% | | Australia | 865 | 6.85% | 17.6% | 76% | | Singapore | 132 | 7.80% | 19.9% | 95% | | Ireland | 118 | 6.60% | 15.5% | 88% | | Finland | 115 | 5.90% | 23.6% | 71% | ### Market Position New Zealand ranks third among the five assessed peers, with its USD 122 million market supported by 851,000 disabled residents and nationally coordinated equipment-funding pathways. ### Growth Advantage New Zealand's 7.19% forecast CAGR exceeds Australia's 6.85%, Ireland's 6.60% and Finland's 5.90%, although it remains below Singapore's technology-led 7.80% trajectory. ### Competitive Strengths Approximately 50,000 publicly funded equipment recipients, established clinical-assessment networks and approved supplier lists support recurring demand, while 900,000 older residents strengthen private-pay mobility purchases. Comprehensive analysis of key factors shaping the market, including growth catalysts, operational challenges, and emerging opportunities across production, distribution, and consumer segments. --- ## Growth Drivers # CHAPTER 7 - Growth Drivers, Challenges & Opportunities Comprehensive analysis of key factors shaping the New Zealand Mobility Aid Market, including growth catalysts, operational challenges, and emerging opportunities across production, distribution, and consumer segments. ## Growth Drivers ### Ageing Population and Independent Living Demand New Zealand had approximately **900,000 people aged 65+ (2025, New Zealand)**, enlarging the structural user base for mobility equipment. * The population aged 65 years or older is expected to reach **one million people (2028, New Zealand)**, increasing demand for rollators, manual wheelchairs, scooters and home-based transfer aids. Suppliers with accessible retail locations and home demonstrations can capture private-pay expenditure. * Disability prevalence among older people was approximately **35% (2023, New Zealand)**, indicating that population ageing has a stronger impact on mobility demand than headline population growth. Product portfolios must cover progressive functional decline rather than only permanent severe disability. * New Zealand's resident population reached **5.325 million people (June 2025, New Zealand)**. Even moderate penetration gains create meaningful equipment demand because mobility aids require periodic replacement, maintenance, battery renewal and reassessment as user needs change. ### Public Equipment Funding and Unmet Need Approximately **50,000 people receive equipment and modification services annually (2025, New Zealand)**, creating a recurring institutional demand base. * Environmental support programmes serve approximately **100,000 people annually (2025, New Zealand)**. Approved suppliers benefit from predictable referral pathways, while clinical assessment requirements favour companies able to provide demonstrations, fitting, documentation and post-delivery support. * Approximately **62% of disabled people (2023, New Zealand)** reported at least one unmet support need. The gap includes assistive equipment, care and accommodation, indicating latent demand that could be converted through faster assessments, flexible funding and lower-cost product formats. * Budget 2025 included average annual new operating expenditure of **NZD 255 million for Disability Support Services (2025, New Zealand)**. Funding supports system stability, but suppliers must demonstrate total-cost value because new appropriations also increase scrutiny of utilisation, procurement and service outcomes. ### Premium Powered and Configured Mobility Adoption Approved powered-wheelchair configurations extend beyond **NZD 20,000 per unit (2025, New Zealand)**, expanding the premium equipment and service profit pool. * Lower-configuration powered wheelchairs are listed at approximately **NZD 5,000–6,000 (2025, New Zealand)**, widening access to powered mobility while preserving room for distributor, fitting and maintenance revenue. Portfolio tiering allows suppliers to serve both standard and complex users. * Enable New Zealand currently contracts **four named suppliers (2026, New Zealand)** for funded power-wheelchair supply in its regions. Approved-range participation creates an entry barrier and directs value toward suppliers with regulatory, clinical and technical-service capability. * One major specialist distributor lists **51 mobility-scooter products (2026, New Zealand)**, illustrating the depth of private-retail assortment. Compact, foldable and travel-compatible equipment can expand demand beyond clinically funded users into lifestyle and convenience purchases. --- ## Market Challenges ### Import Dependence and Foreign Exchange Exposure Estimated import dependence exceeds **80% of market value (2025, New Zealand)**, exposing suppliers to exchange-rate, freight and manufacturer allocation risks. * Wheelchair imports increased from **NZD 9.9 million in 2010 to NZD 15.4 million in 2019**, before distribution and service margins. Import growth confirms limited domestic manufacturing depth and a reliance on international components, finished products and electronic systems. * Powered wheelchairs contain batteries, motors, controllers and specialised seating sourced through global supply chains. A **5% landed-cost movement (planning sensitivity, 2025)** can materially compress distributor margins when public procurement prices cannot be adjusted immediately. * Suppliers must notify covered devices within **30 calendar days (current regulation, New Zealand)** of becoming a sponsor. Overseas manufacturers without capable local sponsors face a practical market-access barrier covering traceability, device records, recalls and post-market communication. ### Funding Constraints and Procurement Pressure Approximately **62% of disabled people reported unmet needs (2023, New Zealand)**, indicating that funded supply does not fully match demand. * Public programmes must balance volume growth, complex cases and product inflation within fixed appropriations. The addition of **NZD 255 million average annual DSS operating expenditure (Budget 2025)** supports capacity but does not remove the requirement for prioritisation and cost controls. * ACC reported rehabilitation equipment expenditure running **8% favourable to budget (December 2025, New Zealand)** following a lower cost per claim and product-mix changes. Procurement actions that improve scheme sustainability can reduce premium-product volumes or shift suppliers toward lower-cost configurations. * ACC equipment expenditure was also **5% below the prior-year level (December 2025, New Zealand)**. Suppliers dependent on a single public funding channel therefore face revenue volatility and should diversify into private retail, aged care, maintenance and institutional contracts. ### Regional Service and Repair Complexity Serving a population of **5.325 million across two main islands (2025, New Zealand)** raises delivery, demonstration and maintenance costs. * Approximately **50,000 funded equipment recipients annually (2025, New Zealand)** require assessment, fitting, repair and replacement coverage beyond major cities. Service delays can affect user safety and contract performance, making technician density a competitive differentiator. * One national supplier operates from **five listed regional locations (2026, New Zealand)**, illustrating the infrastructure required for national healthcare coverage. Smaller entrants may need authorised repair partners rather than wholly owned branches. * High-configuration powered wheelchairs can exceed **NZD 20,000 per unit (2025, New Zealand)**. Long repair cycles create significant user disruption and working-capital exposure, strengthening the value of spare-parts inventory, loan fleets and preventive maintenance contracts. --- ## Market Opportunities ### Refurbishment, Reissue and Lifecycle Services A service population of **50,000 equipment recipients annually (2025, New Zealand)** creates recurring refurbishment, repair and reconfiguration revenue. * **Monetizable angle, 2026–2031:** suppliers can combine equipment sales with maintenance plans, battery replacement, sanitisation, seating reconfiguration and certified refurbishment, increasing revenue per installed unit while reducing dependence on new-product transactions. * **Beneficiary base, approximately 100,000 people annually:** public funders gain lower lifecycle costs, users receive faster access and distributors improve workshop utilisation. Refurbished equipment is most viable where frames retain value but user-specific components can be replaced. * **Required change, service-level tracking from 2026:** procurement frameworks must recognise residual asset value, standardise refurbishment quality and allow suppliers to recover logistics, inspection and warranty costs through transparent lifecycle pricing. ### Smart Powered Mobility and Remote Diagnostics Complex powered systems priced above **NZD 20,000 per unit (2025, New Zealand)** support premium technology and service economics. * **Monetizable angle, 7.19% market CAGR through 2031:** remote fault alerts, battery-health monitoring, location services and configurable controls can support software-enabled servicing and reduce costly emergency technician visits. * **Who benefits, 851,000 disabled residents:** users gain uptime and independence, funders gain visibility into equipment utilisation, and suppliers gain differentiated maintenance contracts and proprietary service data. * **Required change, approved-list integration during 2026–2031:** connected features must demonstrate clinical benefit, privacy safeguards, repairability and compatibility with local service networks before public procurement can scale adoption. ### Private Retail and Direct-to-Consumer Expansion Approximately **900,000 residents were aged 65+ (2025, New Zealand)**, supporting a growing private-pay market beyond funded clinical equipment. * **Monetizable angle, 110,000 units in 2025:** retailers can offer travel wheelchairs, rollators, portable scooters, accessories and home trials through omnichannel models, generating faster cash conversion than tender-funded complex equipment. * **Who benefits, 62% with unmet needs in 2023:** users obtain quicker access to lower-complexity products, while specialist retailers capture demand not eligible for public funding. * **Required change, product education and finance options:** retail growth depends on transparent specifications, safe fitting, instalment payment options and clear separation between self-selected aids and equipment requiring clinical prescription. --- --- ## Competitive Landscape # CHAPTER 8 - Competitive Landscape Overview Competition is moderately fragmented, with global manufacturers, New Zealand rehabilitation specialists, healthcare distributors and regional retailers competing through approved product access, clinical support, inventory availability and after-sales service. * **Key players:** 10 * **New Entrants (last 5 yrs):** - ### Company Profiles (Top 10 Players) | Company Name | Market Share | Headquarters | Founding Year | Core Market Focus | | --- | --- | --- | --- | --- | | Cubro Limited | - | Tauranga, New Zealand | - | Walking aids, wheelchairs, mobility equipment, aged-care and community-care products | | Allied Medical Limited | - | Auckland, New Zealand | - | Powered wheelchairs, mobility scooters, manual wheelchairs and daily-living aids | | Invacare New Zealand | - | Auckland, New Zealand | - | Powered mobility, manual wheelchairs, seating and rehabilitation equipment | | Medifab Limited | - | Auckland, New Zealand | 1990 | Complex rehabilitation technology, wheelchairs, custom seating and paediatric mobility | | Permobil New Zealand | - | Timrå, Sweden | 1967 | Premium powered wheelchairs, advanced seating and electronic mobility controls | | Morton & Perry Limited | - | Auckland, New Zealand | - | Powered wheelchairs, custom rehabilitation products and technical support | | Mobility Centre | - | - | - | Retail mobility scooters, wheelchairs, walkers and independent-living aids | | Goldfern Mobility | - | - | - | Mobility scooters, wheelchairs, walking aids, repairs and regional retail services | | BM Enterprises Limited | - | - | - | Assistive technology, rehabilitation equipment and mobility product distribution | | Medix 21 Limited | - | - | - | Healthcare equipment, mobility aids and rehabilitation product supply | The report provides detailed cross-comparison of key players across 4 performance parameters to identify competitive strengths and weaknesses. ### Top 4 Cross-Comparison KPIs * Approved Product Coverage * Service and Repair Turnaround * New Zealand Mobility Revenue Growth * Gross Margin on Equipment Sales ### Analysis Covered * **Market Share Analysis:** Estimates supplier positioning across funded, institutional and private retail channels * **Cross Comparison Matrix:** Benchmarks approved ranges, service coverage, pricing and financial performance * **SWOT Analysis:** Evaluates product access, technical capability, concentration risks and expansion options * **Pricing Strategy Analysis:** Compares standard, premium, configured and lifecycle service pricing approaches * **Company Profiles:** Reviews geographic presence, product focus, partnerships and market positioning --- --- ## Key Stakeholders # CHAPTER 10 - Key Target Audience Key stakeholders who can leverage from this market analysis for investment, strategy, and operational planning. * **Investors:** CAGR, recurring service revenue, working capital, procurement risk * **Corporates:** assortment mix, approved products, margins, regional coverage * **Government:** equipment access, lifecycle cost, equity, service outcomes * **Operators:** inventory turns, fitting capacity, repairs, technician productivity * **Financial institutions:** distributor finance, receivables, currency exposure, demand stability ### What You'll Gain * Market sizing and trajectory * Policy and compliance mapping * Import exposure indicators * Segment structure and levers * Competitive landscape shortlist * CEO-grade risk priorities --- --- ## Research Methodology # CHAPTER 11 - Research Methodology ### Phase 1: Approach #### Desk Research * Reviewed disability prevalence and support needs * Mapped funded equipment procurement pathways * Analysed wheelchair import and pricing data * Assessed supplier products and service coverage #### Primary Research * Interviewed occupational therapists and EMS assessors * Consulted mobility distributor general managers * Engaged rehabilitation equipment product managers * Interviewed users and family caregivers #### Validation and Triangulation * Validated findings across 320 respondents * Reconciled supplier and demand estimates * Cross-checked volumes against import trends * Tested pricing through product catalogues ### Phase 2: Market Size Estimation #### Top-Down Assessment * Disabled population and mobility-limitation incidence * Demand split by care setting and user * Public equipment-recipient and demographic indicators #### Bottom-Up Modeling * Supplier volumes by mobility-aid category * Product ASP, configuration and service benchmarks * Units multiplied by realised supplier revenue #### Forecasting and Scenario Analysis * Ageing, disability prevalence and replacement cycles * Funding, import pricing and technology mix * Baseline, optimistic and constrained projections through 2031 ### Phase 3: Primary Research Coverage #### Scope Item / Segments Coverage spans the New Zealand mobility-aid value chain from equipment sponsorship and distribution through clinical assessment, configuration, use and lifecycle support. * Public Equipment Funding and Assessment * Specialist Suppliers and Distributors * Clinical Rehabilitation and Aged Care * End Users and Caregivers #### Sample Size A total of 320 respondents were engaged across priority cohorts to ensure robust coverage of procurement, supply, clinical and user perspectives. * Public Equipment Funding and Assessment - 72 respondents (EMS Assessors, Procurement Managers) * Specialist Suppliers and Distributors - 68 respondents (General Managers, Product Managers) * Clinical Rehabilitation and Aged Care - 84 respondents (Occupational Therapists, Rehabilitation Physicians) * End Users and Caregivers - 96 respondents (Mobility Aid Users, Family Caregivers) #### Validation and Triangulation Evidence was validated across respondent cohorts and value-chain stages to reconcile equipment demand, realised pricing, procurement volumes and service requirements. * Compared assessor prescriptions with supplier category volumes * Triangulated imports, retail sales and funded supply * Reconciled operational and strategic respondent perspectives * Tested unit economics against published product prices --- ## Frequently Asked Questions # CHAPTER 12 - FAQs #### Q: What was the size of the New Zealand Mobility Aid Market in 2025? **A:** The New Zealand Mobility Aid Market was valued at USD 122 million in 2025. The estimate covers supplier revenue from manual wheelchairs, powered wheelchairs, mobility scooters, walking aids, transfer equipment, configuration services and associated replacement parts. Demand is supported by approximately 851,000 disabled people and 900,000 residents aged 65 years or older. Public equipment programmes remain the largest funding channel, while private retail is significant for walking aids, portable wheelchairs and mobility scooters. **Data used:** USD 122 million market value in 2025; approximately 110,000 units supplied in 2025 **So what:** Suppliers should prioritise product categories that combine recurring replacement demand with configuration and maintenance revenue. #### Q: How fast will the New Zealand Mobility Aid Market grow through 2031? **A:** The market is forecast to grow at a CAGR of 7.19% from 2026 to 2031, reaching USD 185 million in 2031. Value growth will exceed unit growth because powered wheelchairs, premium scooters, modular seating and sensor-enabled equipment will increase their share of sales. Annual unit demand is projected to rise to approximately 150,000 by 2031. Population ageing and equipment replacement provide the demand foundation, while product technology and private-pay retail create incremental upside. **Data used:** 7.19% forecast CAGR during 2026–2031; USD 185 million market value in 2031 **So what:** Investment cases should separate volume-led growth from the faster-growing premium technology and service profit pools. #### Q: Where will the mobility-aid profit pool shift during the forecast period? **A:** Profit will shift toward powered mobility, complex seating, configuration and lifecycle services. Standard walking aids will remain essential but face stronger price competition and lower absolute margins. Powered wheelchairs can range from approximately NZD 5,000 for lower configurations to more than NZD 20,000 for complex systems, supporting greater revenue per user. Suppliers that combine premium products with fitting, preventive maintenance, batteries, spare parts and rapid repairs can generate more resilient margins than companies relying only on equipment resale. **Data used:** Powered-wheelchair price range of approximately NZD 5,000 to above NZD 20,000 in 2025 **So what:** Competitive strategy should target lifetime user value rather than single-product transaction value. #### Q: What is the largest constraint facing mobility-aid suppliers in New Zealand? **A:** The largest constraint is the interaction between import dependence, public procurement controls and national service obligations. More than 80% of market value is estimated to depend on imported finished products or components. Exchange-rate movements and freight costs can raise landed prices, while public procurement contracts may delay price recovery. Suppliers must also maintain repair capability across a geographically dispersed country. The strongest operators mitigate this exposure through diversified manufacturers, regional service partners, spare-parts inventory and private-pay revenue. **Data used:** Estimated import dependence above 80% in 2025; 50,000 funded equipment recipients annually **So what:** Investors should test foreign-exchange sensitivity, supplier concentration and technician coverage before underwriting expansion. #### Q: How does New Zealand compare with relevant international mobility-aid markets? **A:** New Zealand ranks third in the assessed peer group behind Australia and Singapore, but ahead of Ireland and Finland by estimated 2025 market value. Its USD 122 million market is smaller than Australia's USD 865 million market because of population scale, yet New Zealand's 7.19% forecast CAGR is stronger than the assessed rates for Australia, Ireland and Finland. National funding pathways and high disability prevalence support demand, while import dependence limits domestic supply-chain depth. **Data used:** Third-place peer ranking in 2025; 7.19% New Zealand forecast CAGR **So what:** New Zealand offers an attractive specialist market for suppliers able to operate profitably at moderate national scale. #### Q: What demand factor will have the greatest influence on the market? **A:** Population ageing will have the greatest long-term influence because mobility limitation, balance problems and rehabilitation requirements increase with age. New Zealand had approximately 900,000 residents aged 65 years or older in 2025, with the total expected to reach one million around 2028. Ageing will expand demand across multiple price tiers, from walking frames and rollators to mobility scooters and powered wheelchairs. The commercial benefit will extend to retailers, rehabilitation providers, aged-care operators and equipment-service businesses. **Data used:** Approximately 900,000 residents aged 65+ in 2025; one million projected by 2028 **So what:** Suppliers should align product portfolios, retail access and service capacity with older consumers and community-care environments. --- ## Table of Contents # Table of Contents ### Market Report Structure Comprehensive coverage across three strategic phases, Market Assessment, Go-To-Market Strategy, and Survey, delivering end-to-end insights from market analysis and execution roadmap to customer demand validation. ## Market Assessment Phase Supply-side and competitive intelligence covering market sizing, segmentation, competitive dynamics, regulatory landscape, and future forecasts. ### 1. Executive Summary and Approach ### 2. New Zealand Mobility Aid Market Overview #### 2.1 Key Insights and Strategic Recommendations #### 2.2 New Zealand Mobility Aid Market Overview #### 2.3 Definition and Scope #### 2.4 Evolution of Market Ecosystem #### 2.5 Timeline of Key Regulatory Milestones #### 2.6 Value Chain and Stakeholder Mapping #### 2.7 Business Cycle Analysis #### 2.8 Policy and Incentive Landscape ### 3. New Zealand Mobility Aid Market Analysis #### 3.1 Growth Drivers ##### 3.1.1 Ageing Population and Independent Living Demand ##### 3.1.2 Public Equipment Funding and Unmet Need ##### 3.1.3 Premium Powered and Configured Mobility Adoption #### 3.2 Market Challenges ##### 3.2.1 Import Dependence and Foreign Exchange Exposure ##### 3.2.2 Funding Constraints and Procurement Pressure ##### 3.2.3 Regional Service and Repair Complexity #### 3.3 Market Opportunities ##### 3.3.1 Refurbishment, Reissue and Lifecycle Services ##### 3.3.2 Smart Powered Mobility and Remote Diagnostics ##### 3.3.3 Private Retail and Direct-to-Consumer Expansion #### 3.4 Market Trends ##### 3.4.1 Expansion of Powered Mobility Product Mix ##### 3.4.2 Growth of Modular Seating Systems ##### 3.4.3 Increasing Direct-to-Consumer Retail ##### 3.4.4 Lifecycle Cost-Based Procurement #### 3.5 Government Regulation ##### 3.5.1 WAND Medical Device Notification ##### 3.5.2 Sponsor Traceability Obligations ##### 3.5.3 Disability Support Services Funding ##### 3.5.4 ACC Rehabilitation Equipment Procurement ### 4. SWOT Analysis ### 5. Stakeholder Analysis ### 6. Porter's Five Forces Analysis ### 7. New Zealand Mobility Aid Market Size #### 7.1 By Value #### 7.2 By Volume #### 7.3 By Average Selling Price ### 8. New Zealand Mobility Aid Market Segmentation #### 8.1 Product Type ##### 8.1.1 Manual Wheelchairs ##### 8.1.2 Powered Wheelchairs & Mobility Scooters ##### 8.1.3 Walking Aids ##### 8.1.4 Transfer & Positioning Mobility Equipment #### 8.2 Care Setting ##### 8.2.1 Home and Community Care ##### 8.2.2 Hospitals and Rehabilitation Centres ##### 8.2.3 Aged Residential Care ##### 8.2.4 Disability Support and Educational Settings #### 8.3 End User ##### 8.3.1 Older Adults ##### 8.3.2 Adults with Physical Disabilities ##### 8.3.3 Injury Rehabilitation Patients ##### 8.3.4 Paediatric Users #### 8.4 Application ##### 8.4.1 Daily Ambulation ##### 8.4.2 Long-Distance Community Mobility ##### 8.4.3 Post-Acute Rehabilitation ##### 8.4.4 Complex Seating and Postural Support #### 8.5 Distribution Channel ##### 8.5.1 Government-Funded Equipment Services ##### 8.5.2 Specialist Mobility Retailers ##### 8.5.3 Healthcare Institutions and Procurement Panels ##### 8.5.4 Direct-to-Consumer E-Commerce #### 8.6 Technology ##### 8.6.1 Manual and Mechanical ##### 8.6.2 Electrically Powered ##### 8.6.3 Smart Connected and Sensor-Enabled ##### 8.6.4 Custom Modular and 3D-Fitted #### 8.7 Geography ##### 8.7.1 Auckland ##### 8.7.2 Wellington ##### 8.7.3 Canterbury ##### 8.7.4 Rest of New Zealand ### 9. New Zealand Mobility Aid Market Competitive Analysis #### 9.1 Market Share of Key Players (Micro, Small, Medium, Large Enterprises) #### 9.2 Cross Comparison of Key Players ##### 9.2.1 Company Name ##### 9.2.2 Group Size (Large, Medium, or Small as per industry convention) ##### 9.2.3 Approved Product Coverage ##### 9.2.4 Service and Repair Turnaround ##### 9.2.5 New Zealand Mobility Revenue Growth ##### 9.2.6 Gross Margin on Equipment Sales #### 9.3 SWOT Analysis of Top Players #### 9.4 Pricing Analysis #### 9.5 Detailed Profile of Major Companies ##### 9.5.1 Cubro Limited ##### 9.5.2 Allied Medical Limited ##### 9.5.3 Invacare New Zealand ##### 9.5.4 Medifab Limited ##### 9.5.5 Permobil New Zealand ##### 9.5.6 Morton & Perry Limited ##### 9.5.7 Mobility Centre ##### 9.5.8 Goldfern Mobility ##### 9.5.9 BM Enterprises Limited ##### 9.5.10 Medix 21 Limited ### 10. New Zealand Mobility Aid Market End-User Analysis #### 10.1 Procurement Behavior of Key End-Users ##### 10.1.1 Public Equipment Funding Decisions ##### 10.1.2 Aged-Care Procurement Criteria ##### 10.1.3 Rehabilitation Prescription Pathways ##### 10.1.4 Private-Pay Product Selection #### 10.2 Corporate Spend Patterns ##### 10.2.1 Equipment Capital Budgets ##### 10.2.2 Maintenance and Repair Expenditure ##### 10.2.3 Replacement Cycle Expenditure ##### 10.2.4 Fleet and Loan Equipment Costs #### 10.3 Pain Point Analysis by End-User Category ##### 10.3.1 Assessment and Approval Delays ##### 10.3.2 Product Availability Constraints ##### 10.3.3 Repair Turnaround Times ##### 10.3.4 Affordability and Funding Gaps #### 10.4 User Readiness for Adoption ##### 10.4.1 Powered Mobility Readiness ##### 10.4.2 Smart Feature Acceptance ##### 10.4.3 E-Commerce Purchase Readiness ##### 10.4.4 Refurbished Equipment Acceptance #### 10.5 Post-Deployment ROI and Use Case Expansion ##### 10.5.1 Reduced Caregiver Assistance ##### 10.5.2 Improved Community Participation ##### 10.5.3 Reduced Equipment Downtime ##### 10.5.4 Extended Product Lifecycle ### 11. New Zealand Mobility Aid Market Future Size #### 11.1 By Value #### 11.2 By Volume #### 11.3 By Average Selling Price ## Go-To-Market Strategy Phase Entry strategy evaluation, execution roadmap, partner recommendations, and profitability outlook. ### 1. Whitespace Analysis and Business Model Canvas #### 1.1 Regional Service Coverage Gaps #### 1.2 Refurbished Equipment Business Model #### 1.3 Smart Mobility Service Subscriptions #### 1.4 Private-Pay Product Whitespace ### 2. Marketing and Positioning Recommendations #### 2.1 Clinical Outcome Positioning #### 2.2 Independence and Lifestyle Messaging #### 2.3 Total Cost of Ownership Evidence #### 2.4 Caregiver and Wh?nau Engagement ### 3. Distribution Plan #### 3.1 Approved Funding Channel Access #### 3.2 Specialist Retail Partnerships #### 3.3 Aged-Care Procurement Coverage #### 3.4 Direct E-Commerce Fulfilment ### 4. Channel and Pricing Gaps #### 4.1 Entry-Level Powered Mobility #### 4.2 Regional Demonstration Availability #### 4.3 Transparent Lifecycle Pricing #### 4.4 Consumer Finance Availability ### 5. Unmet Demand and Latent Needs #### 5.1 Faster Equipment Access #### 5.2 Rural Repair Coverage #### 5.3 Portable Travel Mobility #### 5.4 Custom Paediatric Solutions ### 6. Customer Relationship #### 6.1 Clinical Education Programmes #### 6.2 User Onboarding and Training #### 6.3 Preventive Maintenance Engagement #### 6.4 Digital Service Communication ### 7. Value Proposition #### 7.1 Reliable National Support #### 7.2 Clinically Appropriate Product Range #### 7.3 Faster Repair Turnaround #### 7.4 Lower Lifecycle Ownership Cost ### 8. Key Activities #### 8.1 Device Sponsorship and Compliance #### 8.2 Inventory and Parts Management #### 8.3 Clinical Demonstration and Fitting #### 8.4 Repairs and Refurbishment ### 9. Entry Strategy Evaluation #### 9.1 Domestic Market Entry Strategy ##### 9.1.1 Appoint New Zealand Device Sponsor ##### 9.1.2 Secure Clinical Distribution Partner ##### 9.1.3 Build Approved-Range Evidence ##### 9.1.4 Establish National Repair Coverage #### 9.2 Export Entry Strategy ##### 9.2.1 Australia and Pacific Distributor Mapping ##### 9.2.2 Product Certification Alignment ##### 9.2.3 Regional Spare-Parts Infrastructure ##### 9.2.4 International Clinical Reference Development ### 10. Entry Mode Assessment #### 10.1 Direct Subsidiary #### 10.2 Exclusive Distribution #### 10.3 Multi-Distributor Network #### 10.4 Local Joint Venture ### 11. Capital and Timeline Estimation #### 11.1 Regulatory and Sponsorship Setup #### 11.2 Initial Inventory Investment #### 11.3 Workshop and Technician Capacity #### 11.4 Commercial Ramp-Up Timeline ### 12. Control vs Risk Trade-Off #### 12.1 Brand and Pricing Control #### 12.2 Inventory and Currency Risk #### 12.3 Service Quality Control #### 12.4 Channel Concentration Risk ### 13. Profitability Outlook #### 13.1 Equipment Gross Margin #### 13.2 Configuration Service Margin #### 13.3 Maintenance Revenue Potential #### 13.4 Working Capital Requirements ### 14. Potential Partner List #### 14.1 Clinical Equipment Distributors #### 14.2 Specialist Mobility Retailers #### 14.3 Rehabilitation Service Providers #### 14.4 Aged-Care Procurement Groups ### 15. Execution Roadmap #### 15.1 Phased Plan for Market Entry ##### 15.1.1 Market Setup ##### 15.1.2 Market Entry ##### 15.1.3 Growth Acceleration ##### 15.1.4 Scale and Stabilize #### 15.2 Key Activities and Milestones ##### 15.2.1 Complete Device Notifications ##### 15.2.2 Launch Demonstration Programme ##### 15.2.3 Secure Procurement Panel Access ##### 15.2.4 Expand Regional Service Coverage ## Survey Phase Demand-side primary research conducted through structured interviews and online surveys with end users across priority metros and Tier 2/3 cities to capture consumption behavior, unmet needs, and purchase drivers. ### 1. Research Design and Sample Architecture #### 1.1 Research Objectives and Scope #### 1.2 Sample Size Rationale and Representation #### 1.3 Customer Cohort Definitions #### 1.4 Geographic Coverage - Priority Centres and Regional Communities ### 2. Data Collection Methodology #### 2.1 Structured Interview Framework (50 In-Depth Interviews) ##### 2.1.1 Interview Guide and Question Design ##### 2.1.2 Respondent Recruitment and Screening Criteria ##### 2.1.3 Interview Execution and Quality Control ##### 2.1.4 Qualitative Coding and Insight Extraction #### 2.2 Online Survey Design (200 Structured Surveys) ##### 2.2.1 Survey Instrument and Attribute Coverage ##### 2.2.2 Platform Selection and Distribution Channels ##### 2.2.3 Response Validation and Data Cleaning ##### 2.2.4 Statistical Significance and Margin of Error ### 3. Customer Cohort Profiles #### 3.1 Cohort 1 - Public Equipment Assessors and Funders ##### 3.1.1 Cohort Definition and Size ##### 3.1.2 Key Demand Attributes ##### 3.1.3 Purchase Decision Drivers ##### 3.1.4 Represented Sample Size and Regional Distribution #### 3.2 Cohort 2 - Healthcare and Aged-Care Buyers ##### 3.2.1 Cohort Definition and Size ##### 3.2.2 Key Demand Attributes ##### 3.2.3 Purchase Decision Drivers ##### 3.2.4 Represented Sample Size and Facility Distribution #### 3.3 Cohort 3 - Private-Pay Mobility Users ##### 3.3.1 Cohort Definition and Size ##### 3.3.2 Key Demand Attributes ##### 3.3.3 Purchase Decision Drivers ##### 3.3.4 Represented Sample Size and Regional Distribution #### 3.4 Cohort 4 - Complex Rehabilitation Users ##### 3.4.1 Cohort Definition and Size ##### 3.4.2 Key Demand Attributes ##### 3.4.3 Procurement and Compliance Drivers ##### 3.4.4 Represented Sample Size and Clinical Distribution ### 4. Demand Attributes Analysis #### 4.1 Demographic and Healthcare Influences on Demand ##### 4.1.1 Ageing Population Linkages ##### 4.1.2 Disability Prevalence Impact ##### 4.1.3 Rehabilitation and Injury Demand ##### 4.1.4 Import Dependency on New Zealand Mobility Aid Market #### 4.2 End-User Behavior and Consumption Patterns ##### 4.2.1 Frequency and Volume of Purchases ##### 4.2.2 Replacement and Upgrade Cycles ##### 4.2.3 Brand Loyalty vs. Price Sensitivity Trade-Off ##### 4.2.4 Switching Triggers and Retention Factors #### 4.3 Pricing Perception and Value Assessment ##### 4.3.1 Willingness to Pay Across Cohorts ##### 4.3.2 Price Benchmarking Against Alternatives ##### 4.3.3 Regional Pricing Disparities ##### 4.3.4 Total Cost of Ownership Perception #### 4.4 Quality, Safety, and Compliance Expectations ##### 4.4.1 Quality Standards and Device Requirements ##### 4.4.2 Safety and Regulatory Compliance Awareness ##### 4.4.3 Perception of Domestic vs. Imported Offerings ##### 4.4.4 After-Sales Service and Support Expectations #### 4.5 Cultural, Regional, and Contextual Demand Factors ##### 4.5.1 Regional Demand and Service Hotspots ##### 4.5.2 Wh?nau and Caregiver Influence ##### 4.5.3 Clinical Peer and Association Influence ##### 4.5.4 Digital Adoption and E-Procurement Readiness #### 4.6 Marketing, Awareness, and Channel Influence ##### 4.6.1 Impact of Demonstrations and Disability Events ##### 4.6.2 Role of Digital Marketing and Online Platforms ##### 4.6.3 Distributor and Clinician Influence on Purchase ##### 4.6.4 Manufacturer and Service Partnership Impact ### 5. Unmet Needs and Latent Demand Signals #### 5.1 Gaps Between Current Supply and User Expectations #### 5.2 Latent Demand in Underpenetrated Regions #### 5.3 Willingness to Adopt Smart Mobility Technologies #### 5.4 Pain Points Surfaced Across Cohorts ### 6. Key Findings and Strategic Implications #### 6.1 Top Demand Drivers Ranked by Cohort #### 6.2 Barriers to Purchase and Adoption #### 6.3 High-Priority Customer Segments for Market Entry #### 6.4 Recommendations for Product, Pricing, and Channel Strategy ### Disclaimer ### Contact Us